会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
    • 用于在真核细胞中用于治疗目的的基因的转移和表达的逆转录病毒载体
    • US06312948B1
    • 2001-11-06
    • US09433322
    • 1999-11-03
    • Odile Cohen-Haguenauer
    • Odile Cohen-Haguenauer
    • C12N1563
    • C12N15/86C12N2740/13043C12N2830/32C12N2830/85C12N2840/203C12N2840/206C12N2840/44
    • The invention relates to a recombinantvector for the cloning and/or expression and/or transfer of an exogenous nucleotide sequence characterized in that it consists of any sequence contained in the ClaI—PvuII fragment comprising nucleotides 7702 to 1527 of the sequence given in FIG. 1 and comprising the LTR sequence included between nucleotides 7842 and 144, the PBS site starting at nucleotides 145, the packaging sequence included in the sequences of 250 nucleotides following the end of the LTR sequence, the said sequence being capable of controlling the cloning and/or expression and/or transfer of the exogenous sequence whatever its transcriptional orientation with respect to the transcriptional orientation of the virus. It relates to the use of this vector for the transfer and/or cloning and/or expression of genes, in particular in the contest of gene therapy.
    • 本发明涉及用于克隆和/或表达和/或转移外源核苷酸序列的重组载体,其特征在于其由包含在图1中给出的序列的核苷酸7702至1527的ClaI-PvuII片段中包含的任何序列组成。 1,并且包含核苷酸7842和144之间的LTR序列,从核苷酸145开始的PBS位点,包含在LTR序列结束后的250个核苷酸的序列中的包装序列,所述序列能够控制克隆和/ 或外源序列的表达和/或转移,无论其关于病毒的转录取向的转录方向如何。它涉及该载体用于转移和/或克隆和/或表达基因,特别是在 基因治疗比赛